ANIP logo

ANI Pharmaceuticals, Inc. (ANIP) EBITDA

Annual EBITDA:

$63.12M-$43.48M(-40.79%)
December 31, 2024

Summary

  • As of today, ANIP annual EBITDA is $63.12 million, with the most recent change of -$43.48 million (-40.79%) on December 31, 2024.
  • During the last 3 years, ANIP annual EBITDA has risen by +$60.01 million (+1925.71%).
  • ANIP annual EBITDA is now -40.79% below its all-time high of $106.60 million, reached on December 31, 2023.

Performance

ANIP EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherANIPincome statement metrics

Quarterly EBITDA:

$45.46M+$7.01M(+18.24%)
September 30, 2025

Summary

  • As of today, ANIP quarterly EBITDA is $45.46 million, with the most recent change of +$7.01 million (+18.24%) on September 30, 2025.
  • Over the past year, ANIP quarterly EBITDA has increased by +$49.41 million (+1252.15%).
  • ANIP quarterly EBITDA is now at all-time high.

Performance

ANIP Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherANIPincome statement metrics

TTM EBITDA:

$144.84M+$49.41M(+51.78%)
September 30, 2025

Summary

  • As of today, ANIP TTM EBITDA is $144.84 million, with the most recent change of +$49.41 million (+51.78%) on September 30, 2025.
  • Over the past year, ANIP TTM EBITDA has increased by +$74.91 million (+107.13%).
  • ANIP TTM EBITDA is now at all-time high.

Performance

ANIP TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherANIPincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

ANIP EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-40.8%+1252.2%+107.1%
3Y3 Years+1925.7%+216.3%+2121.4%
5Y5 Years+3.9%+221.1%+547.8%

ANIP EBITDA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-40.8%+1925.7%at high+1252.2%at high+2121.4%
5Y5-Year-40.8%+1925.7%at high+767.1%at high>+9999.0%
All-TimeAll-Time-40.8%+224.3%at high+388.4%at high+363.8%

ANIP EBITDA History

DateAnnualQuarterlyTTM
Sep 2025
-
$45.46M(+18.2%)
$144.84M(+51.8%)
Jun 2025
-
$38.45M(+3.9%)
$95.43M(+23.6%)
Mar 2025
-
$36.99M(+54.6%)
$77.20M(+10.4%)
Dec 2024
$63.12M(-40.8%)
$23.93M(+706.4%)
$69.95M(+0.0%)
Sep 2024
-
-$3.95M(-119.5%)
$69.92M(-33.6%)
Jun 2024
-
$20.23M(-32.0%)
$105.30M(-7.0%)
Mar 2024
-
$29.74M(+24.4%)
$113.26M(+2.8%)
Dec 2023
$106.60M(+325.7%)
$23.91M(-23.9%)
$110.21M(+4.2%)
Sep 2023
-
$31.43M(+11.5%)
$105.80M(+19.2%)
Jun 2023
-
$28.19M(+5.6%)
$88.74M(+40.0%)
Mar 2023
-
$26.69M(+36.9%)
$63.40M(+93.1%)
Dec 2022
$25.04M(+703.6%)
$19.50M(+35.7%)
$32.83M(+403.5%)
Sep 2022
-
$14.37M(+404.6%)
$6.52M(+9688.2%)
Jun 2022
-
$2.85M(+173.3%)
-$68.00K(-105.4%)
Mar 2022
-
-$3.88M(+43.0%)
$1.25M(-93.4%)
Dec 2021
$3.12M(-88.9%)
-$6.82M(-187.6%)
$19.08M(-49.2%)
Sep 2021
-
$7.78M(+86.6%)
$37.57M(-14.5%)
Jun 2021
-
$4.17M(-70.1%)
$43.95M(+10.8%)
Mar 2021
-
$13.94M(+19.4%)
$39.67M(+36.5%)
Dec 2020
$28.13M(-53.7%)
$11.68M(-17.5%)
$29.07M(+30.0%)
Sep 2020
-
$14.16M(>+9900.0%)
$22.36M(-10.6%)
Jun 2020
-
-$109.00K(-103.3%)
$25.00M(-43.0%)
Mar 2020
-
$3.34M(-32.7%)
$43.87M(-28.1%)
Dec 2019
$60.73M(-11.4%)
$4.97M(-70.4%)
$61.04M(-19.9%)
Sep 2019
-
$16.80M(-10.5%)
$76.20M(-2.4%)
Jun 2019
-
$18.76M(-8.5%)
$78.06M(+4.3%)
Mar 2019
-
$20.50M(+1.9%)
$74.87M(+8.4%)
Dec 2018
$68.55M(+21.7%)
$20.13M(+7.9%)
$69.10M(+7.5%)
Sep 2018
-
$18.66M(+19.8%)
$64.27M(+3.6%)
Jun 2018
-
$15.58M(+5.7%)
$62.04M(+2.4%)
Mar 2018
-
$14.73M(-3.7%)
$60.56M(+5.9%)
Dec 2017
$56.31M(+33.0%)
$15.30M(-6.9%)
$57.16M(+2.7%)
Sep 2017
-
$16.43M(+16.6%)
$55.65M(+4.8%)
Jun 2017
-
$14.10M(+24.4%)
$53.11M(+5.9%)
Mar 2017
-
$11.33M(-17.9%)
$50.16M(+2.2%)
Dec 2016
$42.35M(+6.8%)
$13.79M(-0.7%)
$49.11M(+12.4%)
Sep 2016
-
$13.89M(+24.5%)
$43.69M(+8.4%)
Jun 2016
-
$11.15M(+8.5%)
$40.30M(+3.4%)
Mar 2016
-
$10.28M(+22.6%)
$38.98M(-1.6%)
Dec 2015
$39.64M(+64.9%)
$8.38M(-20.2%)
$39.60M(-8.5%)
Sep 2015
-
$10.50M(+6.8%)
$43.27M(+2.6%)
Jun 2015
-
$9.83M(-9.8%)
$42.16M(+37.9%)
Mar 2015
-
$10.89M(-9.6%)
$30.58M(+28.0%)
Dec 2014
$24.04M(+1311.9%)
$12.05M(+28.4%)
$23.88M(+251.1%)
Sep 2014
-
$9.39M(+635.1%)
$6.80M(+589.2%)
Jun 2014
-
-$1.75M(-141.8%)
-$1.39M(+57.4%)
Mar 2014
-
$4.20M(+183.5%)
-$3.27M(+68.1%)
Dec 2013
$1.70M(+106.3%)
-$5.03M(-521.7%)
-$10.24M(-32.2%)
Sep 2013
-
$1.19M(+132.9%)
-$7.75M(+45.6%)
Jun 2013
-
-$3.63M(-30.7%)
-$14.25M(+20.2%)
Mar 2013
-
-$2.78M(-9.5%)
-$17.86M(+18.8%)
Dec 2012
-$27.23M
-$2.53M(+52.3%)
-$21.98M(+21.0%)
Sep 2012
-
-$5.31M(+26.7%)
-$27.81M(+21.6%)
Jun 2012
-
-$7.24M(-4.9%)
-$35.49M(+14.0%)
DateAnnualQuarterlyTTM
Mar 2012
-
-$6.90M(+17.5%)
-$41.28M(+17.7%)
Dec 2011
-$50.78M(-12.0%)
-$8.36M(+35.7%)
-$50.14M(+8.7%)
Sep 2011
-
-$12.99M(+0.2%)
-$54.91M(-3.4%)
Jun 2011
-
-$13.02M(+17.4%)
-$53.12M(-5.6%)
Mar 2011
-
-$15.76M(-20.1%)
-$50.29M(-15.8%)
Dec 2010
-$45.34M(-18.4%)
-$13.13M(-17.2%)
-$43.44M(-24.4%)
Sep 2010
-
-$11.20M(-9.8%)
-$34.92M(-22.2%)
Jun 2010
-
-$10.20M(-14.4%)
-$28.59M(-24.4%)
Mar 2010
-
-$8.91M(-93.4%)
-$22.98M(-27.0%)
Dec 2009
-$38.29M(-113.1%)
-$4.61M(+5.3%)
-$18.10M(-13.1%)
Sep 2009
-
-$4.87M(-6.1%)
-$16.00M(+10.2%)
Jun 2009
-
-$4.59M(-13.7%)
-$17.81M(+1.4%)
Mar 2009
-
-$4.03M(-60.7%)
-$18.06M(-0.5%)
Dec 2008
-$17.97M(-109.2%)
-$2.51M(+62.4%)
-$17.97M(-2.9%)
Sep 2008
-
-$6.68M(-38.0%)
-$17.46M(-35.2%)
Jun 2008
-
-$4.84M(-22.9%)
-$12.91M(-21.0%)
Mar 2008
-
-$3.94M(-96.8%)
-$10.67M(-24.3%)
Dec 2007
-$8.59M(-341.5%)
-$2.00M(+5.9%)
-$8.59M(-474.2%)
Sep 2007
-
-$2.13M(+18.2%)
$2.30M(-36.0%)
Jun 2007
-
-$2.60M(-40.2%)
$3.59M(-8.5%)
Mar 2007
-
-$1.86M(-120.9%)
$3.92M(+58.1%)
Dec 2006
$3.56M(+138.7%)
$8.88M(+1161.5%)
$2.48M(+127.9%)
Sep 2006
-
-$836.80K(+63.1%)
-$8.89M(+11.3%)
Jun 2006
-
-$2.27M(+31.2%)
-$10.02M(+3.7%)
Mar 2006
-
-$3.30M(-32.6%)
-$10.41M(-4.6%)
Dec 2005
-$9.20M(+24.4%)
-$2.49M(-26.6%)
-$9.95M(+14.6%)
Sep 2005
-
-$1.96M(+26.1%)
-$11.65M(+7.6%)
Jun 2005
-
-$2.66M(+6.5%)
-$12.61M(-0.4%)
Mar 2005
-
-$2.84M(+32.0%)
-$12.56M(-3.2%)
Dec 2004
-$12.16M(-104.3%)
-$4.18M(-42.9%)
-$12.16M(-26.1%)
Sep 2004
-
-$2.93M(-12.4%)
-$9.65M(-18.2%)
Jun 2004
-
-$2.60M(-6.3%)
-$8.16M(-14.0%)
Mar 2004
-
-$2.45M(-46.9%)
-$7.16M(-20.7%)
Dec 2003
-$5.95M(-60.1%)
-$1.67M(-15.7%)
-$5.93M(-26.9%)
Sep 2003
-
-$1.44M(+10.1%)
-$4.68M(-16.2%)
Jun 2003
-
-$1.60M(-31.4%)
-$4.02M(-3.2%)
Mar 2003
-
-$1.22M(-198.5%)
-$3.90M(-3.1%)
Dec 2002
-$3.72M(-39.0%)
-$409.10K(+48.2%)
-$3.78M(-12.9%)
Sep 2002
-
-$790.40K(+46.6%)
-$3.35M(-48.8%)
Jun 2002
-
-$1.48M(-34.1%)
-$2.25M(-35.8%)
Mar 2002
-
-$1.10M(-4982.7%)
-$1.66M(-32.4%)
Dec 2001
-$2.68M(+19.3%)
$22.60K(-92.7%)
-$1.25M(+42.4%)
Sep 2001
-
$307.80K(+134.8%)
-$2.18M(+30.7%)
Jun 2001
-
-$885.20K(-26.8%)
-$3.14M(+15.7%)
Mar 2001
-
-$698.00K(+22.6%)
-$3.73M(-5.8%)
Dec 2000
-$3.31M(-118.9%)
-$901.40K(-37.5%)
-$3.52M(-35.6%)
Sep 2000
-
-$655.80K(+55.4%)
-$2.60M(-11.2%)
Jun 2000
-
-$1.47M(-198.8%)
-$2.33M(-100.2%)
Mar 2000
-
-$492.40K(-2240.9%)
-$1.17M(-73.1%)
Dec 1999
-$1.51M(+39.9%)
-
-
Dec 1999
-
$23.00K(+105.8%)
-$673.60K(+3.3%)
Sep 1999
-
-$393.60K(-29.9%)
-$696.60K(-129.9%)
Jun 1999
-
-$303.00K
-$303.00K
Dec 1998
-$2.52M
-
-

FAQ

  • What is ANI Pharmaceuticals, Inc. annual EBITDA?
  • What is the all-time high annual EBITDA for ANI Pharmaceuticals, Inc.?
  • What is ANI Pharmaceuticals, Inc. annual EBITDA year-on-year change?
  • What is ANI Pharmaceuticals, Inc. quarterly EBITDA?
  • What is the all-time high quarterly EBITDA for ANI Pharmaceuticals, Inc.?
  • What is ANI Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?
  • What is ANI Pharmaceuticals, Inc. TTM EBITDA?
  • What is the all-time high TTM EBITDA for ANI Pharmaceuticals, Inc.?
  • What is ANI Pharmaceuticals, Inc. TTM EBITDA year-on-year change?

What is ANI Pharmaceuticals, Inc. annual EBITDA?

The current annual EBITDA of ANIP is $63.12M

What is the all-time high annual EBITDA for ANI Pharmaceuticals, Inc.?

ANI Pharmaceuticals, Inc. all-time high annual EBITDA is $106.60M

What is ANI Pharmaceuticals, Inc. annual EBITDA year-on-year change?

Over the past year, ANIP annual EBITDA has changed by -$43.48M (-40.79%)

What is ANI Pharmaceuticals, Inc. quarterly EBITDA?

The current quarterly EBITDA of ANIP is $45.46M

What is the all-time high quarterly EBITDA for ANI Pharmaceuticals, Inc.?

ANI Pharmaceuticals, Inc. all-time high quarterly EBITDA is $45.46M

What is ANI Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?

Over the past year, ANIP quarterly EBITDA has changed by +$49.41M (+1252.15%)

What is ANI Pharmaceuticals, Inc. TTM EBITDA?

The current TTM EBITDA of ANIP is $144.84M

What is the all-time high TTM EBITDA for ANI Pharmaceuticals, Inc.?

ANI Pharmaceuticals, Inc. all-time high TTM EBITDA is $144.84M

What is ANI Pharmaceuticals, Inc. TTM EBITDA year-on-year change?

Over the past year, ANIP TTM EBITDA has changed by +$74.91M (+107.13%)
On this page